Tag: GLP1

Mumbai: As the pricing war in India’s GLP-1 therapy market intensifies, Danish drugmaker Novo Nordisk has sharply reduced prices of its blockbuster semaglutide brands Ozempic and Wegovy to expand ...

New Delhi: India's drug regulator has asked the state drug controllers to strengthen monitoring of the end-to-end supply chain of the GLP-1-based weight loss drugs to ensure strict adherence ...

The Drugs Controller of India has intensified its regulatory surveillance to uphold ethical pharmaceutical practices across the GLP-1 weight loss drugs supply chain, with a focus on curbing unauthorised ...

London: Taking GLP-1 drugs for diabetes has been shown to lower the risk of adverse heart events, but a new analysis found that going off the medication - even ...

Chocolate sales are rising faster among U.S. users of GLP-1 weight-loss drugs than in the rest of the population, Swiss chocolatier Lindt & Spruengli said on Tuesday, citing data ...

Mumbai: Fifteen years ago much before the boom sparked by anti-obesity drugs like Ozempic (semaglutide) and Mounjaro (tirzepatide), a group of scientists at Indian drug maker Zydus Lifesciences had ...

Semaglutide offers a therapeutic approach that not only lowers blood sugar but also addresses excess weight and the cardio-renal risks that often shape long-term outcomes for people with type ...

Synthetic GLP1 used in obesity treatment can have a range of side effects, which vary depending on the medication. Orlistat commonly causes gastrointestinal issues such as diarrhea, flatulence, and ...